Skip to main content

JPMORGAN CHASE & CO

Position in AMLX — Amylyx Pharmaceuticals, Inc.

CIK 19617 NEW YORK, NY

Position in AMLX

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$33,471,153
+$31,251,839 QoQ
Shares Held
1,863,650
+1067.2% QoQ
Ownership
1.67%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#17
of 207 holders
Holding Since
Mar 2022
18 quarters on record
Voting authority Sole 89% Shared 0% None 11%

Common Shares in AMLX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

JPMORGAN CHASE & CO holds $2,415,050,910 across 61 Drug Manufacturers - Specialty & Generic names. AMLX ranks #11 (1.4% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in AMLX

Export CSV
18 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $33,471,153 1,863,650
2026-03-31 $2,219,314 159,663
2025-12-31 $803,887 66,547
2025-09-30 $487,119 35,844
2025-06-30 $564,008 87,989
2025-03-31 $191,404 54,069
2024-12-31 $210,190 55,606
2024-09-30 $455,410 140,559
2024-06-30 $109,270 57,511
2024-03-31 $1,163,713 409,759
2023-12-31 $1,058,191 71,888
2023-09-30 $1,665,568 90,965
2023-06-30 $4,104,684 190,296
2023-03-31 $2,983,877 101,700
2022-12-31 $1,836,451 49,701
2022-09-30 $542,281 19,264
2022-06-30 $118,102 6,132
2022-03-31 $57,786 4,497